ConductScience.org, home

Paper36902165

Modified mRNA as a Treatment for Myocardial Infarction.

Wang Y and 2 others. Int J Mol Sci, 2023. Cited by 10 papers, by iCite.

Cite this record

ConductScience Library. Modified mRNA as a Treatment for Myocardial Infarction. Papers, record 36902165. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36902165

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Modified mRNA as a Treatment for Myocardial Infarction.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
10
iCite
Relative citation ratio, by iCite
1
iCite
Revised in PubMed
2023-03-14
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wang YYu
2Wu MMeiping
3Guo HHaidonghttps://orcid.org/0000-0001-9346-6819

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Gene Transfer TechniquesMajor topic
Myocardial InfarctionMajor topic
Animals
RNA, Messenger
Myocytes, Cardiac
Genetic Therapy

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
82174120National Natural Science Foundation of ChinaPubMed
21ZR1463100Natural Science Foundation of ShanghaiPubMed
22XD1423400Program of Shanghai Academic Research LeaderPubMed

Source PubMed

Download CSV of grants

References90

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124018375Driving vascular endothelial cell fate of human multipotent Isl1+ heart progenitors with VEGF modified mRNA.Cell Res2013https://conductscience.org/library/papers/24018375PubMed
231425721Cell-mediated delivery of VEGF modified mRNA enhances blood vessel regeneration and ameliorates murine critical limb ischemia.J Control Release2019https://conductscience.org/library/papers/31425721PubMed
330638957Improving mRNA-Based Therapeutic Gene Delivery by Expression-Augmenting 3' UTRs Identified by Cellular Library Screening.Mol Ther2019https://conductscience.org/library/papers/30638957PubMed
435960324Pseudouridine and N1-Methylpseudouridine Display pH-Independent Reaction Rates with Bisulfite Yielding Ribose Adducts.Org Lett2022https://conductscience.org/library/papers/35960324PubMed
531712433mRNA structure regulates protein expression through changes in functional half-life.Proc Natl Acad Sci U S A2019https://conductscience.org/library/papers/31712433PubMed
627690187Polymer-Lipid Nanoparticles for Systemic Delivery of mRNA to the Lungs.Angew Chem Int Ed Engl2016https://conductscience.org/library/papers/27690187PubMed
726213960Screening of mRNA Chemical Modification to Maximize Protein Expression with Reduced Immunogenicity.Pharmaceutics2015https://conductscience.org/library/papers/26213960PubMed
836051878Host-pathogen protein-nucleic acid interactions: A comprehensive review.Comput Struct Biotechnol J2022https://conductscience.org/library/papers/36051878PubMed
929520567Optimization of Synthetic mRNA for Highly Efficient Translation and its Application in the Generation of Endothelial and Hematopoietic Cells from Human and Primate Pluripotent Stem Cells.Stem Cell Rev Rep2018https://conductscience.org/library/papers/29520567PubMed
1032728595Synthetic mRNA Encoding VEGF-A in Patients Undergoing Coronary Artery Bypass Grafting: Design of a Phase 2a Clinical Trial.Mol Ther Methods Clin Dev2020https://conductscience.org/library/papers/32728595PubMed
1130639256Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications.Adv Drug Deliv Rev2019https://conductscience.org/library/papers/30639256PubMed
1226401041Rotavirus Controls Activation of the 2'-5'-Oligoadenylate Synthetase/RNase L Pathway Using at Least Two Distinct Mechanisms.J Virol2015https://conductscience.org/library/papers/26401041PubMed
1335077739Delivery of modified mRNA to damaged myocardium by systemic administration of lipid nanoparticles.J Control Release2022https://conductscience.org/library/papers/35077739PubMed
1427910045Synthesis of Modified mRNA for Myocardial Delivery.Methods Mol Biol2017https://conductscience.org/library/papers/27910045PubMed
1526375005Epicardial FSTL1 reconstitution regenerates the adult mammalian heart.Nature2015https://conductscience.org/library/papers/26375005PubMed
1616111635Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA.Immunity2005https://conductscience.org/library/papers/16111635PubMed
1720709074Adult stem cells for cardiac tissue engineering.J Mol Cell Cardiol2011https://conductscience.org/library/papers/20709074PubMed
1825108892A neonatal blueprint for cardiac regeneration.Stem Cell Res2014https://conductscience.org/library/papers/25108892PubMed
1932057366Mesenchymal stem cell-derived extracellular vesicles alone or in conjunction with a SDKP-conjugated self-assembling peptide improve a rat model of myocardial infarction.Biochem Biophys Res Commun2020https://conductscience.org/library/papers/32057366PubMed
2029106412Short poly(A) tails are a conserved feature of highly expressed genes.Nat Struct Mol Biol2017https://conductscience.org/library/papers/29106412PubMed

See all 90 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.

PMIDTitleJournalYearIn PapersSource
41515935Modified mRNA-Based Therapeutic Strategies for Myocardial Ischemia-Reperfusion Injury.Int J Mol Sci2025https://conductscience.org/library/papers/41515935PubMed
40847431Revolutionizing cardiac fibrosis treatment: the potential of personalized CAR T-cell therapy.Cardiooncology2025https://conductscience.org/library/papers/40847431PubMed
39470057Cardiomyocyte-Specific Overexpression of Activated Yes-Associated Protein Modified-RNA Promotes Cardiomyocyte Proliferation and Myocardial Regeneration.J Am Heart Assoc2024https://conductscience.org/library/papers/39470057PubMed
38203180Molecular Research on Heart Protection.Int J Mol Sci2023https://conductscience.org/library/papers/38203180PubMed
37110734Nanotechnology Lighting the Way for Gene Therapy in Ophthalmopathy: From Opportunities toward Applications.Molecules2023https://conductscience.org/library/papers/37110734PubMed

Download CSV of cited by

Genes11

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36902165

GET https://conductscience.org/api/papers/v1/36902165/references?page=2